Jianghua Ding & Shengping Gong. (2024). Quadruplet regimen for newly diagnosed multiple myeloma is effective in the standard-risk subgroup but not in the high-risk subgroup. Frontiers Media S.A..
Chicago Style (17th ed.) CitationJianghua Ding and Shengping Gong. Quadruplet Regimen for Newly Diagnosed Multiple Myeloma Is Effective in the Standard-risk Subgroup but Not in the High-risk Subgroup. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationJianghua Ding and Shengping Gong. Quadruplet Regimen for Newly Diagnosed Multiple Myeloma Is Effective in the Standard-risk Subgroup but Not in the High-risk Subgroup. Frontiers Media S.A., 2024.
Warning: These citations may not always be 100% accurate.